Guidelines for the Management of Osteoporosis and Fragility Fractures

Overview

Journal Intern Emerg Med

Publisher Springer

Specialties Emergency Medicine
General Medicine

Date 2018 Jun 28

PMID 29948835

Citations 125

Authors

Ranuccio Nuti

Maria Luisa Brandi

Giovanni Checchia

Ombretta Di Munno

Ligia Dominguez

Paolo Falaschi

Carmelo Erio Fiore

Giovanni Iolascon

Stefania Maggi

Raffaella Michieli

Silvia Migliaccio

Salvatore Minisola

Maurizio Rossini

Giuseppe Sessa

Umberto Tarantino

Antonella Toselli

Giovanni Carlo Isaia

Affiliations

Soon will be listed here.

Abstract

The purpose of this document, a result of the harmonisation and revision of Guidelines published separately by the SIMFER, SIOMMMS/SIR, and SIOT associations, is to provide practical indications based on specific levels of evidence and various grades of recommendations, drawn from available literature, for the management of osteoporosis and for the diagnosis, prevention, and treatment of fragility fractures. These indications were discussed and formally approved by the delegates of the Italian Scientific Associations involved in the project (SIE, SIGG, SIMFER, SIMG, SIMI, SIOMMMS, SIR, and SIOT).

Citing Articles

The Role of Magnesium, Zinc, and Strontium in Osteoporotic Fracture Repair.

Wang Z, Xiang P, Xu Z, Gu M, Zhang R, Li Y Bioengineering (Basel). 2025; 12(2).

PMID: 40001719 PMC: 11851939. DOI: 10.3390/bioengineering12020201.

A new cut-off value of FRAX tools as an osteoporosis screening tool for Thai geriatric population.

Asavamongkolkul A, Adulkasem N, Vanitcharoenkul E, Chandhanayingyong C, Laohaprasitiporn P, Soparat K Sci Rep. 2025; 15(1):6466.

PMID: 39987166 PMC: 11846872. DOI: 10.1038/s41598-025-90594-z.

The Association of Phytochemical Index and oxidative balance score with bone Mineral density: a case-control study.

Mahmoodi M, Souni F, Shateri Z, Hosseini A, Nouri M, Ghadiri M J Health Popul Nutr. 2025; 44(1):40.

PMID: 39948660 PMC: 11827369. DOI: 10.1186/s41043-025-00747-z.

The role of dietary inflammation in the risk of osteoporosis in Iranian postmenopausal women: a case-control study.

Ghadiri M, Pourghassem Gargari B, Ahmadi M, Nouri M, Shateri Z, Naeini A Sci Rep. 2025; 15(1):5120.

PMID: 39934201 PMC: 11814271. DOI: 10.1038/s41598-025-89649-y.

Melatonin alleviates senile osteoporosis by regulating autophagy and enhancing fracture healing in aged mice.

Zhang D, Zhu T, Bai J, Chen C, Wen J, Zhou Y Bone Joint Res. 2025; 14(2):97-110.

PMID: 39912870 PMC: 11801226. DOI: 10.1302/2046-3758.142.BJR-2024-0112.R2.

References

Lapi F, Simonetti M, Michieli R, Pasqua A, Brandi M, Frediani B . Assessing 5-year incidence rates and determinants of osteoporotic fractures in primary care. Bone. 2011; 50(1):85-90. DOI: 10.1016/j.bone.2011.09.048. View

Gillespie W, Gillespie L, Parker M . Hip protectors for preventing hip fractures in older people. Cochrane Database Syst Rev. 2010; (10):CD001255. DOI: 10.1002/14651858.CD001255.pub4. View

Ganda K, Puech M, Chen J, Speerin R, Bleasel J, Center J . Models of care for the secondary prevention of osteoporotic fractures: a systematic review and meta-analysis. Osteoporos Int. 2012; 24(2):393-406. DOI: 10.1007/s00198-012-2090-y. View

Rizzoli R, Biver E . Glucocorticoid-induced osteoporosis: who to treat with what agent?. Nat Rev Rheumatol. 2014; 11(2):98-109. DOI: 10.1038/nrrheum.2014.188. View

Rossini M, Adami S, Viapiana O, Fracassi E, Idolazzi L, Povino M . Dose-dependent short-term effects of single high doses of oral vitamin D(3) on bone turnover markers. Calcif Tissue Int. 2012; 91(6):365-9. DOI: 10.1007/s00223-012-9637-y. View

Lapi F, Bianchini E, Michieli R, Pasqua A, Cricelli I, Mazzaglia G . Erratum to: Assessing risk of osteoporotic fractures in primary care: development and validation of the FRA-HS algorithm. Calcif Tissue Int. 2017; 100(6):550. DOI: 10.1007/s00223-017-0262-7. View

Maggi S, Noale M, Giannini S, Adami S, Defeo D, Isaia G . Quantitative heel ultrasound in a population-based study in Italy and its relationship with fracture history: the ESOPO study. Osteoporos Int. 2005; 17(2):237-44. DOI: 10.1007/s00198-005-1985-2. View

Rossini M, Adami S, Viapiana O, Ortolani R, Vella A, Fracassi E . Circulating γδ T cells and the risk of acute-phase response after zoledronic acid administration. J Bone Miner Res. 2011; 27(1):227-30. DOI: 10.1002/jbmr.521. View

Cosman F, de Beur S, LeBoff M, Lewiecki E, Tanner B, Randall S . Clinician's Guide to Prevention and Treatment of Osteoporosis. Osteoporos Int. 2014; 25(10):2359-81. PMC: 4176573. DOI: 10.1007/s00198-014-2794-2. View

10.

Neer R, Arnaud C, Zanchetta J, Prince R, Gaich G, Reginster J . Effect of parathyroid hormone (1-34) on fractures and bone mineral density in postmenopausal women with osteoporosis. N Engl J Med. 2001; 344(19):1434-41. DOI: 10.1056/NEJM200105103441904. View

11.

Rizzoli R, Boonen S, Brandi M, Bruyere O, Cooper C, Kanis J . Vitamin D supplementation in elderly or postmenopausal women: a 2013 update of the 2008 recommendations from the European Society for Clinical and Economic Aspects of Osteoporosis and Osteoarthritis (ESCEO). Curr Med Res Opin. 2013; 29(4):305-13. DOI: 10.1185/03007995.2013.766162. View

12.

Aparisi F . Vertebroplasty and Kyphoplasty in Vertebral Osteoporotic Fractures. Semin Musculoskelet Radiol. 2016; 20(4):382-391. DOI: 10.1055/s-0036-1592431. View

13.

Harvey N, McCloskey E, Mitchell P, Dawson-Hughes B, Pierroz D, Reginster J . Mind the (treatment) gap: a global perspective on current and future strategies for prevention of fragility fractures. Osteoporos Int. 2017; 28(5):1507-1529. PMC: 5392413. DOI: 10.1007/s00198-016-3894-y. View

14.

Bjelakovic G, Gluud L, Nikolova D, Whitfield K, Wetterslev J, Simonetti R . Vitamin D supplementation for prevention of mortality in adults. Cochrane Database Syst Rev. 2014; (1):CD007470. PMC: 11285307. DOI: 10.1002/14651858.CD007470.pub3. View

15.

Hodges L, Connolly S, Winter J, Schmidt T, Stevens H, Hayward M . Modulation of gastric pH by a buffered soluble effervescent formulation: A possible means of improving gastric tolerability of alendronate. Int J Pharm. 2012; 432(1-2):57-62. DOI: 10.1016/j.ijpharm.2012.04.073. View

16.

Black D, Delmas P, Eastell R, Reid I, Boonen S, Cauley J . Once-yearly zoledronic acid for treatment of postmenopausal osteoporosis. N Engl J Med. 2007; 356(18):1809-22. DOI: 10.1056/NEJMoa067312. View

17.

Murthy N . Imaging of stress fractures of the spine. Radiol Clin North Am. 2012; 50(4):799-821. DOI: 10.1016/j.rcl.2012.04.009. View

18.

Eastell R, Szulc P . Use of bone turnover markers in postmenopausal osteoporosis. Lancet Diabetes Endocrinol. 2017; 5(11):908-923. DOI: 10.1016/S2213-8587(17)30184-5. View

19.

Parker M, Gillespie W, Gillespie L . Effectiveness of hip protectors for preventing hip fractures in elderly people: systematic review. BMJ. 2006; 332(7541):571-4. PMC: 1397761. DOI: 10.1136/bmj.38753.375324.7C. View

20.

Ma D, Wu L, He Z . Effects of walking on the preservation of bone mineral density in perimenopausal and postmenopausal women: a systematic review and meta-analysis. Menopause. 2013; 20(11):1216-26. DOI: 10.1097/GME.0000000000000100. View